<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Choosing initial treatment for individuals with panic disorder with or without agoraphobia*&lt;sup&gt;¶&lt;/sup&gt;&lt;sup&gt;Δ&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Choosing initial treatment for individuals with panic disorder with or without agoraphobia*<sup>¶</sup><sup>Δ</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Choosing initial treatment for individuals with panic disorder with or without agoraphobia*<sup>¶</sup><sup>Δ</sup></div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes"><p>SSRI: selective serotonin reuptake inhibitor; CBT: cognitive-behavioral therapy.</p>
<p>* This algorithm assumes that the individual does not have active suicidal ideation, plan, or intent.</p>
<p>¶ In some cases, symptoms of panic disorder do not cause significant psychosocial distress or interfere with functioning. These individuals may reasonably elect to forego treatment and monitor symptoms.</p>
<p>Δ We treat all individuals with comorbid disorders (eg, major depression, posttraumatic stress disorder, anxiety) with an SSRI plus CBT. We take into account patient preference in all treatment decisions.</p>
<p>◊ In cases with extreme stress, where the individual is unable to wait for medications to take effect, we treat with intensive CBT (eg, twice weekly or more) providing psychoeducation and support.</p>
<p>§ In cases when the individual is unable to wait one to two weeks (eg, due to severe symptoms), we move on to the next treatment decision more rapidly.</p>
<p>¥ Refer to UpToDate content (and associated algorithm) for subsequent treatment.</p>
<p>‡ We prefer gabapentin over pregabalin due to its lower likelihood for misuse than pregabalin. Mirtazapine is a reasonable alternative agent for individuals with prominent insomnia. Refer to UpToDate content for dose and titration of each of these agents.</p>
† Our preference among benzodiazepines is clonazepam (refer to UpToDate content for administration and dosing of clonazepam).</div><div id="graphicVersion">Graphic 139312 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
